RAS inhibitors, ARB, and ACE inhibitors are prioritized therapies to prevent the development of CKD with proteinuria in patients with hypertension (Kidney Disease: Improving Global Outcomes Blood Pressure Work, G. KDIGO, 2021). Here, ACE is linked to chronic kidney disease.